A Study to Assess the Independent Effects of 4-Factor Prothrombin Complex Concentrate and Tranexamic Acid on Bleeding/Pharmacodynamics in Healthy Participants

NCT02561923 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

158

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Rivaroxaban
DRUG: Tranexamic acid
DRUG: Kcentra, a 4-factor PCC
DRUG: Saline

Sponsor

Janssen Scientific Affairs, LLC

Collaborators

[object Object]